Covington Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $24.8M | Buy |
288,024
+2,269
| +0.8% | +$203K | 1.07% | 23 |
|
|
2022
Q2 | $26.1M | Buy |
285,755
+2,855
| +1% | +$253K | 1.06% | 25 |
|
|
2022
Q1 | $23.2M | Buy |
282,900
+15,491
| +6% | +$1.22M | 0.83% | 31 |
|
|
2021
Q4 | $20.5M | Buy |
267,409
+4,560
| +2% | +$363K | 0.71% | 40 |
|
|
2021
Q3 | $19.7M | Buy |
262,849
+3,618
| +1% | +$275K | 0.75% | 37 |
|
|
2021
Q2 | $20.2M | Sell |
259,231
-14,333
| -5% | -$1.07M | 0.79% | 34 |
|
|
2021
Q1 | $20.1M | Buy |
273,564
+3,193
| +1% | +$236K | 0.86% | 31 |
|
|
2020
Q4 | $21.1M | Buy |
270,371
+10,043
| +4% | +$768K | 0.95% | 30 |
|
|
2020
Q3 | $20.6M | Buy |
260,328
+5,550
| +2% | +$435K | 1.02% | 26 |
|
|
2020
Q2 | $18.8M | Buy |
254,778
+22,507
| +10% | +$1.69M | 1.05% | 25 |
|
|
2020
Q1 | $17.1M | Buy |
232,271
+8,605
| +4% | +$676K | 1.12% | 23 |
|
|
2019
Q4 | $19.4M | Buy |
223,666
+3,326
| +2% | +$273K | 1.02% | 25 |
|
|
2019
Q3 | $17.7M | Buy |
220,340
+188
| +0.1% | +$15.1K | 1.02% | 27 |
|
|
2019
Q2 | $17.6M | Buy |
220,152
+9,676
| +5% | +$741K | 1.05% | 26 |
|
|
2019
Q1 | $16.7M | Sell |
210,476
-1,022
| -0.5% | -$76.4K | 1.03% | 25 |
|
|
2018
Q4 | $15.4M | Sell |
211,498
-2,965
| -1% | -$209K | 1.08% | 21 |
|
|
2018
Q3 | $14.5M | Buy |
214,463
+6,122
| +3% | +$390K | 0.89% | 32 |
|
|
2018
Q2 | $12.1M | Buy |
208,341
+18,507
| +10% | +$1.04M | 0.77% | 36 |
|
|
2018
Q1 | $9.87M | Sell |
189,834
-3,155
| -2% | -$170K | 0.65% | 47 |
|
|
2017
Q4 | $10.4M | Buy |
192,989
+312
| +0.2% | +$17.3K | 0.64% | 50 |
|
|
2017
Q3 | $11.8M | Sell |
192,677
-473
| -0.2% | -$28.7K | 0.78% | 41 |
|
|
2017
Q2 | $11.8M | Buy |
193,150
+2,635
| +1% | +$160K | 0.96% | 36 |
|
|
2017
Q1 | $11.6M | Buy |
190,515
+3,795
| +2% | +$230K | 0.98% | 33 |
|
|
2016
Q4 | $10.5M | Buy |
186,720
+5,211
| +3% | +$305K | 0.93% | 34 |
|
|
2016
Q3 | $10.8M | Sell |
181,509
-69
| -0% | -$4.04K | 0.99% | 33 |
|
|
2016
Q2 | $9.98M | Buy |
181,578
+827
| +0.5% | +$44K | 0.92% | 34 |
|
|
2016
Q1 | $9.13M | Sell |
180,751
-561
| -0.3% | -$27.5K | 0.87% | 37 |
|
|
2015
Q4 | $9.14M | Sell |
181,312
-597
| -0.3% | -$30.1K | 0.89% | 38 |
|
|
2015
Q3 | $8.57M | Buy |
181,909
+2,736
| +2% | +$145K | 0.88% | 41 |
|
|
2015
Q2 | $9.73M | Buy |
179,173
+4,139
| +2% | +$232K | 0.87% | 38 |
|
|
2015
Q1 | $9.6M | Sell |
175,034
-3,216
| -2% | -$182K | 0.92% | 39 |
|
|
2014
Q4 | $9.66M | Sell |
178,250
-706
| -0.4% | -$39.3K | 0.86% | 42 |
|
|
2014
Q3 | $10.1M | Buy |
178,956
+1,310
| +0.7% | +$73.6K | 0.93% | 31 |
|
|
2014
Q2 | $10M | Sell |
177,646
-387
| -0.2% | -$21.1K | 0.91% | 33 |
|
|
2014
Q1 | $9.64M | Buy |
178,033
+3,528
| +2% | +$183K | 0.94% | 30 |
|
|
2013
Q4 | $8.33M | Sell |
174,505
-10,998
| -6% | -$503K | 0.85% | 39 |
|
|
2013
Q3 | $8.43M | Sell |
185,503
-480
| -0.3% | -$21.9K | 0.97% | 27 |
|
|
2013
Q2 | $8.24M | Buy |
+185,983
| New | +$8.31M | 1.01% | 27 |
|
Other funds holding MRK
Covington Capital Management's MRK Position: Q3 2022 in Review
Covington Capital Management increased its Merck (MRK) stake by 0.79% in Q3 2022, buying an estimated $203K and bringing the position to 288,024 shares worth $24.8M. The position accounts for 1.07% of the portfolio, ranked #23.
Covington Capital Management first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. The position peaked at $26.1M in Q2 2022. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.
- Covington Capital Management held 288,024 shares of Merck worth $24.8M as of Q3 2022.
- Covington Capital Management bought 2,269 Merck shares in Q3 2022, an estimated $203K.
- Merck made up 1.07% of Covington Capital Management's portfolio in Q3 2022, its #23 holding.
- Covington Capital Management first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
- Covington Capital Management's Merck position peaked at $26.1M in Q2 2022.
- 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.